Morgan Stanley’s AbbVie ABBV Stock Holding History

Morgan Stanley’s Portfolio ABBV Stock Details ABBV Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$7.74B	Buy	41,700,001 +550,267	+1%	+$102M	0.5%	28
2025 Q1	$8.62B	Buy	41,149,734 +1,460,570	+4%	+$306M	0.62%	25
2024 Q4	$7.05B	Buy	39,689,164 +972,313	+3%	+$173M	0.49%	29
2024 Q3	$7.65B	Buy	38,716,851 +1,473,173	+4%	+$291M	0.55%	26
2024 Q2	$6.39B	Buy	37,243,678 +2,071,989	+6%	+$355M	0.49%	29
2024 Q1	$6.4B	Sell	35,171,689 -32,933,381	-48%	-$6B	0.51%	30
2023 Q4	$10.6B	Buy	68,105,070 +35,929,543	+112%	+$5.57B	0.47%	33
2023 Q3	$4.8B	Buy	32,175,527 +914,485	+3%	+$136M	0.49%	33
2023 Q2	$4.21B	Sell	31,261,042 -166,952	-0.5%	-$22.5M	0.42%	39
2023 Q1	$5.01B	Sell	31,427,994 -143,756	-0.5%	-$22.9M	0.54%	26
2022 Q4	$5.1B	Buy	31,571,750 +4,785,277	+18%	+$773M	0.58%	20
2022 Q3	$3.6B	Buy	26,786,473 +710,939	+3%	+$95.4M	0.49%	34
2022 Q2	$3.99B	Buy	26,075,534 +7,193,804	+38%	+$1.1B	0.52%	28
2022 Q1	$3.06B	Sell	18,881,730 -489,258	-3%	-$79.3M	0.41%	46
2021 Q4	$2.62B	Buy	19,370,988 +384,646	+2%	+$52.1M	0.32%	63
2021 Q3	$2.05B	Buy	18,986,342 +41,655	+0.2%	+$4.49M	0.28%	85
2021 Q2	$2.13B	Buy	18,944,687 +214,425	+1%	+$24.2M	0.28%	73
2021 Q1	$2.03B	Buy	18,730,262 +2,393,757	+15%	+$259M	0.3%	73
2020 Q4	$1.75B	Buy	16,336,505 +2,605,050	+19%	+$279M	0.27%	85
2020 Q3	$1.2B	Buy	13,731,455 +1,296,673	+10%	+$114M	0.23%	100
2020 Q2	$1.22B	Buy	12,434,782 +1,678,372	+16%	+$165M	0.27%	88
2020 Q1	$820M	Buy	10,756,410 +696,233	+7%	+$53M	0.22%	107
2019 Q4	$891M	Buy	10,060,177 +1,195,733	+13%	+$106M	0.21%	111
2019 Q3	$671M	Buy	8,864,444 +43,836	+0.5%	+$3.32M	0.18%	127
2019 Q2	$641M	Sell	8,820,608 -210,121	-2%	-$15.3M	0.17%	132
2019 Q1	$728M	Sell	9,030,729 -3,829,097	-30%	-$309M	0.21%	113
2018 Q4	$1.19B	Buy	12,859,826 +821,082	+7%	+$75.7M	0.35%	55
2018 Q3	$1.14B	Buy	12,038,744 +904,274	+8%	+$85.5M	0.29%	78
2018 Q2	$1.03B	Buy	11,134,470 +348,882	+3%	+$32.3M	0.28%	72
2018 Q1	$1.02B	Buy	10,785,588 +393,689	+4%	+$37.3M	0.28%	72
2017 Q4	$1.01B	Sell	10,391,899 -1,659,304	-14%	-$160M	0.28%	67
2017 Q3	$1.07B	Sell	12,051,203 -1,958,223	-14%	-$174M	0.32%	59
2017 Q2	$1.02B	Sell	14,009,426 -3,165,549	-18%	-$230M	0.31%	62
2017 Q1	$1.12B	Buy	17,174,975 +4,100,545	+31%	+$267M	0.34%	50
2016 Q4	$819M	Buy	13,074,430 +21,781	+0.2%	+$1.36M	0.27%	71
2016 Q3	$823M	Buy	13,052,649 +894,694	+7%	+$56.4M	0.28%	66
2016 Q2	$753M	Buy	12,157,955 +471,647	+4%	+$29.2M	0.27%	76
2016 Q1	$668M	Buy	11,686,308 +990,440	+9%	+$56.6M	0.26%	81
2015 Q4	$634M	Sell	10,695,868 -8,555,771	-44%	-$507M	0.23%	94
2015 Q3	$1.05B	Sell	19,251,639 -22,197,050	-54%	-$1.21B	0.39%	32
2015 Q2	$2.78B	Buy	41,448,689 +29,796,859	+256%	+$2B	0.97%	5
2015 Q1	$682M	Sell	11,651,830 -1,570,148	-12%	-$91.9M	0.25%	84
2014 Q4	$865M	Sell	13,221,978 -893,284	-6%	-$58.5M	0.32%	51
2014 Q3	$815M	Buy	14,115,262 +1,031,599	+8%	+$59.6M	0.31%	54
2014 Q2	$738M	Buy	13,083,663 +2,395,501	+22%	+$135M	0.29%	60
2014 Q1	$549M	Buy	10,688,162 +1,110,966	+12%	+$57.1M	0.23%	87
2013 Q4	$506M	Buy	9,577,196 +3,512,983	+58%	+$186M	0.22%	96
2013 Q3	$271M	Sell	6,064,213 -33,730	-0.6%	-$1.51M	0.13%	182
2013 Q2	$252M	Buy	+6,097,943	New	+$252M	0.13%	197